Al-Azhar Assiut Medical Journal

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 15  |  Issue : 2  |  Page : 122--126

Serum levels of adiponectin and visfatin in patients with lichen planus: a case-controlled study


Sahar A Ismail1, Ibrahim Mwafey2, Sotohy A Mohamed3 
1 Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Assiut University, Egypt
2 Department of Oral Medicine and Periodontology Diagnosis and Oral Radiology, Al-Azhar University Assiut Branch, Egypt
3 Department of Public Health, Faculty of V. Medicine, Assiut University, Assiut, Egypt

Correspondence Address:
Sahar A Ismail
Department of Dermatology, Venereology and Andrology, Assiut University Hospital, Assiut University, 71515 Assiut
Egypt

Background The association of adipokines with lichen planus (LP) is still obscure. Data regarding their effect on other immunological and inflammatory disorders suggest a probable role of adipokines in the pathophysiology of LP. Objective The objective of the study was to investigate serum levels of adiponectin and visfatin in patients with LP compared with healthy controls and to consider their relation to disease duration and obesity markers. Patients and methods A case-controlled study was conducted, which included 49 patients with LP and 40 healthy controls. Adiponectin and visfatin serum levels were measured using enzyme-linked immunosorbent assays. Results Patients with LP showed lower serum levels of adiponectin than healthy controls, with significant inverse correlation with disease duration, BMI, and waist circumference. Cutaneous and mucocutaneous LP showed lower serum levels of adiponectin than oral LP. Visfatin serum level was higher in patients with LP compared with healthy controls, with significant positive correlation with BMI and waist circumference. Conclusion Our data suggested that adiponectin and visfatin act together through modulation of the inflammatory setting of patients with LP. Because of the significant correlations of adiponectin and visfatin with obesity markers, the physical complications of obesity should be emphasized to patients with LP.


How to cite this article:
Ismail SA, Mwafey I, Mohamed SA. Serum levels of adiponectin and visfatin in patients with lichen planus: a case-controlled study.Al-Azhar Assiut Med J 2017;15:122-126


How to cite this URL:
Ismail SA, Mwafey I, Mohamed SA. Serum levels of adiponectin and visfatin in patients with lichen planus: a case-controlled study. Al-Azhar Assiut Med J [serial online] 2017 [cited 2020 Mar 31 ];15:122-126
Available from: http://www.azmj.eg.net/article.asp?issn=1687-1693;year=2017;volume=15;issue=2;spage=122;epage=126;aulast=Ismail;type=0